Tooru plc Reports Unprecedented OAF Sales Growth and Pulsin's Strong Recovery Ahead of Key Retail Launches

OAF Brand Sets New Records in Retail Sales Across Key Retailers

The OAF brand has shown outstanding performance with record week-on-week retail sales, as evidenced by electronic point of sale (EPOS) data from key retail partners. The Board highlighted that this steady sales acceleration signals growing consumer demand for OAF products and enhanced shelf productivity across retail channels. This momentum marks a significant milestone for the brand and highlights the effectiveness of Tooru’s retail strategy in capturing market share within the competitive health and wellness sector.

EPOS data offers objective, real-time insights into consumer purchasing patterns rather than relying solely on forecasts or distributor orders. This transparency is crucial for investors seeking to validate the brand's operational strength beyond management statements. The focus on consistent week-on-week growth suggests sustained consumer interest rather than short-term promotional spikes, indicating meaningful market penetration and repeat purchases among target consumers.

Pulsin Gains Major Retail Partnerships Following 2025 Supply Constraints Recovery

After facing production and stock limitations in late 2025, Pulsin has initiated a structured recovery with major new retail partnerships confirmed. TK Maxx will list Pulsin products across all UK stores starting August 2026. Holland & Barrett plans to launch new Keto flavours exclusively across its UK stores by September 2026, with the Keto Multipack listing following by the end of that month. These partnerships significantly expand the brand’s distribution, as both retailers have extensive UK store networks and consumer bases aligned with health and wellness purchases.

Alongside domestic retail growth, Pulsin has signed agreements with three international distributors to introduce the Kids Nut-Free Bar, Keto Multipacks, and Gut Bars. A distributor in the Netherlands will launch the Keto bar range in the new 35-gram format during Q3 2026, alongside existing SKUs. Ongoing range reviews with domestic and international customers are part of broader listing negotiations. This international expansion validates Pulsin’s market appeal beyond the UK and reflects investor confidence in its product positioning and commercial potential.

Strategic Expansion of Product Portfolio Focused on Kids, Keto, and Functional Categories

Tooru has unveiled multiple new product lines in development and launch phases across Keto, Protein, and Functional categories. The Kids range includes five nut-free, plant-based bars formulated for children aged three and above, targeting a segment with specific nutritional and allergen needs. The Functional range introduces three new Gut Health Bars with probiotic benefits, tapping into rising consumer interest in digestive wellness and microbiome-focused nutrition. These launches extend existing product lines, leveraging brand equity and retail relationships.

The Keto Multipack has been strategically redesigned, increasing individual bar weight from 30g to 35g, enhancing perceived consumer value and improving unit economics. Additional product launches are planned for Q4 2026. This phased approach allows efficient production management, market testing, and supply chain optimization while building momentum through 2026. The focus on three core categories reflects portfolio rationalization to concentrate resources on higher-performing segments.

Margin Improvements Driven by Cost Reductions and Supplier Optimization

Over the past six months, Pulsin has worked with existing and new suppliers to reduce input costs for ingredients and packaging, resulting in improved gross margins. This supplier optimization highlights management’s focus on enhancing unit economics and profitability alongside revenue growth. Although specific margin improvements or cost savings were not disclosed, securing better pricing while maintaining quality suggests prior supply chains were suboptimal, presenting efficiency gains.

The combination of margin improvements and anticipated revenue growth over the next two quarters could amplify profitability if execution and demand meet expectations. The company did not disclose exact margin levels before or after improvements. The ability to reduce input costs while expanding distribution and launching new products indicates operational leverage in the supply chain, potentially providing financial resilience amid challenging market conditions.

Revenue Growth Outlook for the Next Two Quarters

Tooru forecasts significant revenue growth in the next two quarters, driven by new product launches, expanded distribution via major retailers, and additional retail listings. This outlook depends on successful execution of TK Maxx and Holland & Barrett listings starting August and September 2026, respectively, alongside international distributor agreements becoming commercially effective. Pulsin’s revenue is recovering from the constrained trading experienced in late 2025, making the baseline for comparison lower.

The company did not provide absolute revenue figures, growth percentages, or specific guidance ranges. The forecast relies on multiple concurrent factors, including product launch success, consumer acceptance, timely inventory delivery, and consistent retail sell-through. While confident in recovery, actual revenue growth depends on operational execution and consumer demand validation.

EPOS Data Validates Consumer Demand in Competitive Health Sector

Highlighting EPOS data for OAF reflects a broader industry trend toward real-time, objective sales measurement as proof of consumer demand. EPOS systems capture actual transactions, offering detailed insights into basket composition, pricing sensitivity, and purchase frequency. Tooru’s emphasis on consistent week-on-week EPOS growth shows robust data collection and analysis across retail partners. In the competitive health and wellness market, which includes functional foods and supplements, EPOS performance provides transparent evidence of market traction.

The health and wellness market continues to grow as consumers become more aware of nutrition, functional benefits, and ingredient quality. Competition among branded health bars, protein products, and keto foods is intense, with many established and emerging brands vying for shelf space and consumer attention. OAF’s strong EPOS performance and Pulsin’s recovery indicate meaningful competitive positioning. Investors should track EPOS metrics and retail sell-through as indicators of brand health and momentum.

International Distribution Strategy Enhances Geographic Diversification

The three international distributor agreements for Pulsin products reflect Tooru’s strategy to diversify revenue beyond the UK and reduce domestic retail concentration risk. The Netherlands distributor will launch the Keto bar range in the new 35g format in Q3 2026, showing product adaptation to international preferences and compliance. Ongoing range reviews with international customers suggest a pipeline of further distribution opportunities.

International expansion in health and wellness requires attention to regulatory compliance, cultural preferences, and differing retail channel structures. Securing multiple international distributor agreements indicates confidence in product-market fit across geographies, though revenue contributions remain to be validated. Geographic diversification may stabilize revenue streams and reduce UK market exposure, though investors should monitor margin comparability between international and domestic channels.

Portfolio Diversification Across Juvela, OAF, and Pulsin Brands

Tooru operates multiple health and wellness brands—Juvela, OAF, and Pulsin—targeting distinct consumer segments and nutritional needs. While the July 2026 update focuses on OAF and Pulsin, CEO Scott Livingston noted "excellent progress from both Juvela and OAF," indicating Juvela’s positive performance. This multi-brand strategy diversifies revenue and addresses various market segments with specialized products and marketing.

The portfolio serves consumers with specific dietary needs (e.g., coeliac disease via Juvela), lifestyle-focused customers (OAF’s fitness and active lifestyle positioning), and functional health consumers (Pulsin’s Keto, Protein, and Functional ranges). This segmentation offers resilience against challenges in any single brand or segment but requires management resources to maintain distinct brand identities, supply chains, and distribution. Investors should monitor investment balance across brands and watch for margin or distribution challenges signaling broader operational issues.

Management Outlook Emphasizes Accelerated Growth Potential

CEO Scott Livingston expressed encouragement over positive trading momentum and confidence that Tooru is "well positioned to accelerate growth and continue building value across the portfolio." Management highlighted strong EBITDA delivery and revenue growth, alongside progress from Juvela and OAF. The outlook suggests confidence beyond near-term recovery toward sustained growth driven by product launches, retail partnerships, and margin improvements.

No specific quantitative guidance on EBITDA, revenue growth rates, or strategic milestones was provided beyond product launch and retail listing timelines. Management’s commentary reflects confidence based on current momentum and retail commitments rather than binding forward guidance. Investors should understand that achieving "accelerated growth" depends on successful execution of multiple factors, including product reception, retail performance, and favorable market conditions. The announcement was classified as inside information under Market Abuse Regulations, indicating its materiality to shareholders and investors.

Execution Risks and Investor Monitoring Recommendations

The July 2026 update outlines an ambitious operational schedule for the remainder of 2026, including retail listings starting August and September, multiple product launches, and significant revenue growth targets. Success depends on manufacturing capacity to fulfill TK Maxx and Holland & Barrett orders at scale, product quality and shelf life management, consumer acceptance of new products and Keto Multipack redesign, and sustained retail partner support through autumn and winter. Supply chain disruptions, quality issues, or weaker consumer demand could impact growth plans.

Investors should monitor key milestones such as in-store availability at TK Maxx from August 2026, Holland & Barrett Keto flavour and Multipack availability by September 2026, and early sell-through data for new products. Quarterly trading updates and half-year financial reports should be reviewed for revenue growth, margin improvements, and guidance changes signaling execution challenges. Past supply constraints in late 2025 highlight risks in scaling production and distribution, warranting close attention to supply chain updates.